Jeff June – Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
Jeff June, Innovation Advisor at Early Stage Digital Health, MedTech, Venture Capital, and Accelerator Programs, posted on LinkedIn:
”I just published an article (click link or image below) about a grant program to advance your start up in spatial biology.
I’m also including my abstract (also in the article link) for leveraging a Miltenyi Biotec MACS Imaging Grant to apply spatial biology in stroke care.
I hope people in my network will apply for this opportunity (looking at you University Lab Partners, BioTools Innovator, MedTech Innovator, National Science Foundation (NSF), Gates Foundation).
I encourage anyone exploring spatial biology, imaging, or molecular diagnostics to apply before October 31st.
For me, this was more than an application – it’s part of how we’re redefining stroke diagnostics at Ischemia Care. Our RNA-based assay (ISCDx) has already shown that blood can reveal the mechanism of stroke, but this next step uses spatial biology to see those molecular interactions: how hashtag#vascular and immune cells communicate, how inflammation drives recurrence, and how molecular signatures translate into clinical outcomes.
As we enter a new era of cardiovascular and neurovascular medicine, integrating molecular diagnostics + AI + spatial imaging isn’t just exciting science – it’s how we’ll prevent the next stroke (or maybe someday any stroke) before it happens.
If you’re working at this intersection, or building translational tools that turn biology into actionable data, let’s connect. This is where the next generation of precision care begins.”
Stay updated with Hemostasis Today.
-
Oct 11, 2025, 09:06Natalia Peres Martinez - Surgical Bleed: Replacing Gut Feeling With Guided Thinking
-
Oct 11, 2025, 09:00Muhammad Ali - Hematology In Pakistan: The Silent Revolution In Diagnosis And A Blueprint For Growth
-
Oct 11, 2025, 08:50Robert Zeiser: New Insights and Timeless Lessons in Transplantation
-
Oct 11, 2025, 08:39Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
-
Oct 11, 2025, 08:33RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 11, 2025, 18:47Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
-
Oct 11, 2025, 08:49Rodrigo Assar: We Are Pushing the Boundaries by Using Computational Approaches
-
Oct 11, 2025, 08:48Deborah Wild: Thrilled to See GeneVentiv Selected for The NIH NHLBI Catalyze Program
-
Oct 11, 2025, 08:34Ivo Francischetti and Colleagues on Glycoprotein VI Contributing to Platelet Activation in HIT
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 11, 2025, 08:57Jeff June - Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
-
Oct 11, 2025, 08:11Khaled Musallam: Honored to Be Featured for The 7th Year in A Row in The World’s Top 2% Most-Cited Scientists
-
Oct 11, 2025, 08:07Britta Diebel: This Has Been An Intense, Good Week, Although IPAW Actually Lasts All Year Long
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?